Literature DB >> 8646682

Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome.

J I Risinger1, J C Barrett, P Watson, H T Lynch, J Boyd.   

Abstract

BACKGROUND: The hereditary nonpolyposis colorectal carcinoma (HNPCC) syndrome is an autosomal dominant genetic disorder caused by the inheritance of a mutation in one of a family of genes encoding DNA mismatch repair (MMR) proteins. HNPCC manifests as genetic instability in linked tumors. Clinically, the syndrome is characterized by early onset malignancies, primarily of the colon and endometrium, with an increased incidence of tumors at other gastrointestinal sites, upper urologic tract, ovary, and pancreas as well. However, the inclusion of breast cancer as an integral tumor of this syndrome is controversial.
METHODS: Mutation screening of MMR genes was carried out by single strand conformation polymorphism (SSCP) and sequencing analyses of genomic DNA prepared from normal lymphocytes. Expression analysis was performed by SSCP. Sequence analyses of cDNA was prepared from breast tumor tissue and normal lymphocytes. Genetic instability was assessed by comparing the electrophoretic mobility of polymerase chain reaction (PCR) products using multiple microsatellite markers.
RESULTS: A 4-bp frameshift mutation in the hMLH1 gene was found to segregate with disease in the germlines of the affected members of a large kindred HNPCC. Expression of only the mutant allele was observed in the breast cancer tissue of one family member, however both alleles were observed in her normal tissue. This breast cancer exhibited widespread microsatellite instability, as did breast cancers obtained from several other HNPCC kindreds.
CONCLUSIONS: These data indicate that breast cancer may result from the inheritance of a mutant MMR gene, and that breast cancer may occur as an integral tumor in the HNPCC syndrome.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8646682     DOI: 10.1002/(SICI)1097-0142(19960501)77:9<1836::AID-CNCR12>3.0.CO;2-0

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  34 in total

1.  Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds.

Authors:  R J Scott; M McPhillips; C J Meldrum; P E Fitzgerald; K Adams; A D Spigelman; D du Sart; K Tucker; J Kirk
Journal:  Am J Hum Genet       Date:  2000-12-07       Impact factor: 11.025

2.  Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer?

Authors:  H F Vasen; H Morreau; J W Nortier
Journal:  Am J Hum Genet       Date:  2001-06       Impact factor: 11.025

Review 3.  Prophylactic surgery in Lynch syndrome.

Authors:  V Celentano; G Luglio; G Antonelli; R Tarquini; L Bucci
Journal:  Tech Coloproctol       Date:  2011-02-02       Impact factor: 3.781

Review 4.  Genetic susceptibility to non-polyposis colorectal cancer.

Authors:  H T Lynch; A de la Chapelle
Journal:  J Med Genet       Date:  1999-11       Impact factor: 6.318

5.  Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry.

Authors:  Michael D Walsh; Daniel D Buchanan; Margaret C Cummings; Sally-Ann Pearson; Sven T Arnold; Mark Clendenning; Rhiannon Walters; Diane M McKeone; Amanda B Spurdle; John L Hopper; Mark A Jenkins; Kerry D Phillips; Graeme K Suthers; Jill George; Jack Goldblatt; Amanda Muir; Kathy Tucker; Elise Pelzer; Michael R Gattas; Sonja Woodall; Susan Parry; Finlay A Macrae; Robert W Haile; John A Baron; John D Potter; Loic Le Marchand; Bharati Bapat; Stephen N Thibodeau; Noralane M Lindor; Michael A McGuckin; Joanne P Young
Journal:  Clin Cancer Res       Date:  2010-03-09       Impact factor: 12.531

6.  Hereditary breast and ovarian cancer.

Authors:  Jacek Gronwald; Tomasz Byrski; Tomasz Huzarski; Oleg Oszurek; Anna Janicka; Jolanta Szymanska-Pasternak; Bohdan Górski; Janusz Menkiszak; Izabella Rzepka-Górska; Jan Lubinski
Journal:  Hered Cancer Clin Pract       Date:  2008-06-15       Impact factor: 2.857

7.  Familial breast and bowel cancer: does it exist?

Authors:  Rodney J Scott; Katie A Ashton
Journal:  Hered Cancer Clin Pract       Date:  2004-02-15       Impact factor: 2.857

8.  Lynch syndrome-associated breast cancers do not overexpress chromosome 11-encoded mucins.

Authors:  Michael D Walsh; Margaret C Cummings; Sally-Ann Pearson; Mark Clendenning; Rhiannon J Walters; Belinda Nagler; John L Hopper; Mark A Jenkins; Graeme K Suthers; Jack Goldblatt; Kathy Tucker; Michael R Gattas; Julie L Arnold; Susan Parry; Finlay A Macrae; Michael A McGuckin; Joanne P Young; Daniel D Buchanan
Journal:  Mod Pathol       Date:  2013-02-01       Impact factor: 7.842

Review 9.  Breast cancer susceptibility: current knowledge and implications for genetic counselling.

Authors:  Tim Ripperger; Dorothea Gadzicki; Alfons Meindl; Brigitte Schlegelberger
Journal:  Eur J Hum Genet       Date:  2008-12-17       Impact factor: 4.246

10.  Thyroid cancer in a patient with a germline MSH2 mutation. Case report and review of the Lynch syndrome expanding tumour spectrum.

Authors:  Rein P Stulp; Johanna C Herkert; Arend Karrenbeld; Bart Mol; Yvonne J Vos; Rolf H Sijmons
Journal:  Hered Cancer Clin Pract       Date:  2008-02-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.